Literature DB >> 31392501

The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction.

Limei Ai1, Weiwei Guo1, Wei Chen2, Yun Teng3, Liping Bai4,5.   

Abstract

The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas system has emerged as the dominating tool for genome engineering, while also changes the speed and efficiency of metabolic engineering in conventional and non-conventional yeasts. Among these CRISPR-Cas systems, CRISPR-Cas9 technology has usually been applied for removing unfavorable target genes. Here, we used CRISPR-Cas9 technology to delete the gal80 gene in uracil-deficient strain and had successfully remolded the engineered Saccharomyces cerevisiae that can produce artemisinic acid without galactose induction. An L9(34) orthogonal test was adopted to investigate the effects of different factors on artemisinic acid production. Fermentation medium III with sucrose as carbon sources, 1% inoculum level, and 84-h culture time were identified as the optimal fermentation conditions. Under this condition, the maximum artemisinic acid production by engineered S. cerevisiae 1211-2 was 740 mg/L in shake-flask cultivation level. This study provided an effective approach to reform metabolic pathway of artemisinic acid-producing strain. The engineered S. cerevisiae 1211-2 may be applied to artemisinic acid production by industrial fermentation in the future.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31392501     DOI: 10.1007/s00284-019-01752-2

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  36 in total

1.  The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.

Authors:  Youyou Tu
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

Review 2.  Transcriptional control of the GAL/MEL regulon of yeast Saccharomyces cerevisiae: mechanism of galactose-mediated signal transduction.

Authors:  P J Bhat; T V Murthy
Journal:  Mol Microbiol       Date:  2001-06       Impact factor: 3.501

3.  Engineering of the pyruvate dehydrogenase bypass in Saccharomyces cerevisiae for high-level production of isoprenoids.

Authors:  Yoichiro Shiba; Eric M Paradise; James Kirby; Dae-Kyun Ro; Jay D Keasling
Journal:  Metab Eng       Date:  2006-11-17       Impact factor: 9.783

4.  Quick and easy yeast transformation using the LiAc/SS carrier DNA/PEG method.

Authors:  R Daniel Gietz; Robert H Schiestl
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 5.  Systems biology of GAL regulon in Saccharomyces cerevisiae.

Authors:  Venkat Reddy Pannala; Paike Jayadeva Bhat; Sharad Bhartiya; K V Venkatesh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Jan-Feb

6.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast.

Authors:  Dae-Kyun Ro; Eric M Paradise; Mario Ouellet; Karl J Fisher; Karyn L Newman; John M Ndungu; Kimberly A Ho; Rachel A Eachus; Timothy S Ham; James Kirby; Michelle C Y Chang; Sydnor T Withers; Yoichiro Shiba; Richmond Sarpong; Jay D Keasling
Journal:  Nature       Date:  2006-04-13       Impact factor: 49.962

7.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids.

Authors:  Vincent J J Martin; Douglas J Pitera; Sydnor T Withers; Jack D Newman; Jay D Keasling
Journal:  Nat Biotechnol       Date:  2003-06-01       Impact factor: 54.908

8.  Marker-disruptive gene integration and URA3 recycling for multiple gene manipulation in Saccharomyces cerevisiae.

Authors:  Shohei Kaneko; Tsutomu Tanaka; Hideo Noda; Hideki Fukuda; Rinji Akada; Akihiko Kondo
Journal:  Appl Microbiol Biotechnol       Date:  2009-05-20       Impact factor: 4.813

9.  Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase.

Authors:  Eric M Paradise; James Kirby; Rossana Chan; Jay D Keasling
Journal:  Biotechnol Bioeng       Date:  2008-06-01       Impact factor: 4.530

10.  Control of yeast GAL genes by MIG1 repressor: a transcriptional cascade in the glucose response.

Authors:  J O Nehlin; M Carlberg; H Ronne
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  2 in total

1.  De novo biosynthesis of rubusoside and rebaudiosides in engineered yeasts.

Authors:  Yameng Xu; Xinglong Wang; Chenyang Zhang; Xuan Zhou; Xianhao Xu; Luyao Han; Xueqin Lv; Yanfeng Liu; Song Liu; Jianghua Li; Guocheng Du; Jian Chen; Rodrigo Ledesma-Amaro; Long Liu
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

2.  Engineered Saccharomyces cerevisiae for the De Novo Biosynthesis of (-)-Menthol.

Authors:  Xueqin Lv; Xuan Zhou; Jun Ma; Mengrui Tao; Yanfeng Liu; Jianghua Li; Guocheng Du; Long Liu
Journal:  J Fungi (Basel)       Date:  2022-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.